For people diagnosed with macular telangiectasia type 2 (MacTel)—a rare and slowly progressing retinal disease—there have ...

Home OCT offers personalized insights on treatment response for wet age-related macular degeneration that may help reduce ...

For people diagnosed with macular telangiectasia type 2 (MacTel)-a rare and slowly progressing retinal disease-there have ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...

Direct selective laser trabeculoplasty is not yet noninferior to SLT in lowering IOP, but secondary endpoints show promise.

Patients with glaucoma often demonstrate poor adherence to prescribed treatment plans with prostaglandin analogues, which decreases over time.